Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Anus Neoplasms × Capecitabine × Clear all

Phase

Phase 2 5 Phase 1 3 Phase 3 2 Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 9 Rectal Neoplasms 6 Pancreatic Neoplasms 5 Neoplasms 3 Colorectal Neoplasms 3 Stomach Neoplasms 1 Solid Tumors 1 Obesity 1 Neoplasm Metastasis 1 Locally Advanced Rectal Cancer 1 Klatskin Tumor 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Cholangitis, Sclerosing 1 Carcinoma, Hepatocellular 1 Capecitabine 1 Biliary Tract Neoplasms 1 Anus Neoplasms 1 Adenocarcinoma 1

Interventions

Early Intervention, Educational 2 Yoga 1 Toothbrushing 1 Surgical Flaps 1 Serotonin Plasma Membrane Transport Proteins 1 Radiotherapy, Intensity-Modulated 1 Psychiatric Rehabilitation 1 Parturition 1 Papanicolaou Test 1 Observation 1 Mitomycin 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Fluorouracil 1 Dietary Supplements 1 Diet Therapy 1 Diagnostic Tests, Routine 1 Counseling 1 Capecitabine 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05838391 2026-02-03

Adaptive Radiation in Anal Cancer

Columbia University

Phase NA Recruiting

Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡